Page last updated: 2024-10-17

aminocaproic acid and Esophageal Neoplasms

aminocaproic acid has been researched along with Esophageal Neoplasms in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grover, N1
Johnson, A1
Bespalov, VG1
Aleksandrov, VA1
Petrov, AS1
Troian, DN1

Other Studies

2 other studies available for aminocaproic acid and Esophageal Neoplasms

ArticleYear
Aminocaproic acid used to control upper gastrointestinal bleeding in radiation gastritis.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:5

    Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Esophageal Neoplasms; Gastritis; Gastrointestinal

1997
[The inhibiting effect of epsilon-aminocaproic acid on the incidence of induced tumors of the esophagus, nervous system and kidneys].
    Voprosy onkologii, 1992, Volume: 38, Issue:1

    Topics: Aminocaproic Acid; Animals; Anticarcinogenic Agents; Carcinogens; Chi-Square Distribution; Dimethyln

1992